Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
- PMID: 17940942
- DOI: 10.1086/520545
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
Abstract
Although Ebola virus (EBOV) is transmitted by unprotected physical contact with infected persons, few data exist on which specific bodily fluids are infected or on the risk of fomite transmission. Therefore, we tested various clinical specimens from 26 laboratory-confirmed cases of Ebola hemorrhagic fever, as well as environmental specimens collected from an isolation ward, for the presence of EBOV. Virus was detected by culture and/or reverse-transcription polymerase chain reaction in 16 of 54 clinical specimens (including saliva, stool, semen, breast milk, tears, nasal blood, and a skin swab) and in 2 of 33 environmental specimens. We conclude that EBOV is shed in a wide variety of bodily fluids during the acute period of illness but that the risk of transmission from fomites in an isolation ward and from convalescent patients is low when currently recommended infection control guidelines for the viral hemorrhagic fevers are followed.
Similar articles
-
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.J Infect Dis. 1999 Feb;179 Suppl 1:S28-35. doi: 10.1086/514318. J Infect Dis. 1999. PMID: 9988162
-
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.J Infect Dis. 1999 Feb;179 Suppl 1:S170-6. doi: 10.1086/514291. J Infect Dis. 1999. PMID: 9988181
-
Environmental Contamination and Persistence of Ebola Virus RNA in an Ebola Treatment Center.J Infect Dis. 2016 Oct 15;214(suppl 3):S145-S152. doi: 10.1093/infdis/jiw198. Epub 2016 Jun 30. J Infect Dis. 2016. PMID: 27365495
-
[Ebola virus: what the practitioner needs to know].Med Trop (Mars). 1998;58(2):177-86. Med Trop (Mars). 1998. PMID: 9791600 Review. French.
-
Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.Bull Soc Pathol Exot. 2005 Sep;98(3):210-7. Bull Soc Pathol Exot. 2005. PMID: 16267963 Review.
Cited by
-
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.PLoS One. 2012;7(12):e52986. doi: 10.1371/journal.pone.0052986. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285243 Free PMC article.
-
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor.Viruses. 2012 Aug;4(8):1279-88. doi: 10.3390/v4081279. Epub 2012 Aug 15. Viruses. 2012. PMID: 23012625 Free PMC article.
-
Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.Virol J. 2012 Jun 13;9:111. doi: 10.1186/1743-422X-9-111. Virol J. 2012. PMID: 22695180 Free PMC article.
-
Perspectives towards antiviral drug discovery against Ebola virus.J Med Virol. 2019 Dec;91(12):2029-2048. doi: 10.1002/jmv.25357. Epub 2019 Sep 30. J Med Virol. 2019. PMID: 30431654 Free PMC article. Review.
-
"Filoviruses": a real pandemic threat?EMBO Mol Med. 2009 Apr;1(1):10-8. doi: 10.1002/emmm.200900005. EMBO Mol Med. 2009. PMID: 20049699 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical